Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by CARRICK THERAPEUTICS LIMITED
Carrick Therapeutics Announces First Patient Dosed in Phase 1b/2 Clinical Trial of Samuraciclib in Combination with Vepdegestrant in Patients with Advanced Breast Cancer
February 14, 2024
From
CARRICK THERAPEUTICS LIMITED
Via
GlobeNewswire
Tickers
ARVN
PFE
Carrick Therapeutics Announces First Patient Dosed in Phase 2b Clinical Trial of Samuraciclib in Combination with Fulvestrant in Patients with Advanced HR+, HER2- Breast Cancer
December 15, 2023
From
CARRICK THERAPEUTICS LIMITED
Via
GlobeNewswire
Carrick Therapeutics Announces U.S. FDA Clearance of IND for CT7439, a First-In-Class Inhibitor of CDK12/13
September 07, 2023
From
CARRICK THERAPEUTICS LIMITED
Via
GlobeNewswire
Carrick Therapeutics Announces Clinical Trial Collaboration with Arvinas and Pfizer to Evaluate Samuraciclib and Vepdegestrant Combination
July 06, 2023
From
CARRICK THERAPEUTICS LIMITED
Via
GlobeNewswire
Tickers
ARVN
PFE
Carrick Therapeutics Closes Series C Financing
December 01, 2022
From
CARRICK THERAPEUTICS LIMITED
Via
GlobeNewswire
Carrick Therapeutics Announces $35 Million Investment from Pfizer
December 01, 2022
From
CARRICK THERAPEUTICS LIMITED
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.